Skip to content

Evaluation of the impact of foods containing probiotics from a person's gut microbiota on that their gut microbiota

Evaluation of the impact of foods containing probiotics from a person's gut microbiota on that their gut microbiota - Evaluation of the impact of foods containing probiotics from a person's gut microbiota on that their gut microbiota

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000053892
Enrollment
30
Registered
2025-04-01
Start date
2024-01-31
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adult

Interventions

Intake test food for 1week &gt
follow up for 3 weeks

Sponsors

Bacterico
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Male and female participants aged 20 to under 60 years at the time of consent acquisition. 2. Individuals who have received sufficient explanation about the trial, can understand its content, and from whom consent has been obtained personally.

Exclusion criteria

Exclusion criteria: 1. Individuals who regularly use specific health foods, functional foods, health supplements, supplements, probiotics, etc., more than three times a week, which could potentially affect the trial, and cannot discontinue them from the time of consent acquisition. 2. Individuals who have taken medications (e.g., antibiotics, intestinal regulators, laxatives, etc.) that may potentially affect the trial within 3 months prior to consent acquisition. 3. Individuals deemed unsuitable as trial subjects based on the responses to the background survey in the preliminary investigation. 4. Heavy alcohol drinkers. 5. Individuals with a history or current presence of serious diseases of the heart, liver, kidneys, digestive system, etc. 6. Pregnant, breastfeeding, or individuals intending to become pregnant during the trial period. 7. Individuals with allergies to medications or food. 8. Individuals participating in other clinical trials for drugs or health foods, within 4 weeks after the end of such trials, or planning to participate in another clinical trial after consenting to participate in this trial. 9. Individuals whom the trial investigator deems inappropriate for participation in the study.

Design outcomes

Primary

MeasureTime frame
Relative abundance of Bifidobacterium

Secondary

MeasureTime frame
Gut microbiota analysis Subjective evaluation questionnaire on depression, activity levels, and sleep quality

Countries

Japan

Contacts

Public ContactNatsuki Suganuma

bacterico Research and Development Department

info@bacterico.co.jp06-4397-3516

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026